Original language | English |
---|---|
Pages (from-to) | S728 |
Journal | Annals of Oncology |
Volume | 32 |
DOIs | |
Publication status | Published - 1 Sept 2021 |
725MO Phase I study of the combination of the dual RAF/MEK inhibitor VS-6766 and the FAK inhibitor defactinib: Results of efficacy in low grade serous ovarian cancer
Sampriti Banerjee, Rafael Grochot, R. Shinde, Julianne Lima, Matthew Krebs, Rabik Rahman, Martin Little, Nina Tunariu, A. Curcean, H. Badham, M. Mahmud, A. Turner, Mahesh Parmar, Christina Yap, Anna Minchom, J. Lopez, J. Bono, Udoyan Banerji
Research output: Contribution to journal › Meeting Abstract › peer-review